While originally developed for managing type 2 diabetes, Ozempic has garnered attention for its weight loss benefits, making it a potentially valuable tool for women navigating weight management during menopause
Published studies concern the developers controlled investigational material
In a double blinded placebo controlled phase 3 study, obese patients were treated with either daily Rybelsus (50 mg) or placebo for 68 weeks
At 10 mg weekly, that same vial lasts only 5 weeks
Though the diabetes-attributable risk of MACE do not appear to be decreasing in the last decades, it is expected that the absolute rates of events will decline owing to an expanding proportion of patients receiving cardiorenal protective drugs and to the adherence to guideline-recommended targets for blood pressure and serum lipids
Trulicity (dulaglutide) comes in the form of a pre-filled, single-dose pen with an autoinjector that is needle-free, as the needle is inside the pen